|
Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease Clinical research trials and Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease. Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease  Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease
Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease
For Condition: Coronary Disease
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: This study is designed to compare two different echocardiographic techniques in the evaluation of heart disease (coronary artery disease). Both tests called Myocardial Contrast Echocardiography with Pharmacologic Stress and Stress Echocardiography with Dobutamine, are performed using a standard echocardiographic machine. Myocardial Contrast Echocardiography (MCE) does not use radioactivity. It uses sound waves like standard echocardiography. However, with MCE patients receive an injection of a "contrast agent" directly into the blood stream through a vein. The contrast agent, called Optison, is made of tiny microbubbles smaller than red blood cells. The echocardiogram can detect these microbubbles in the small blood vessels of the heart muscle and allow researchers to find areas of the heart receiving less blood flow than others. It is important to observe the heart during exercise because there are changes in blood flow. Since MCE cannot be performed when the patient is exercising, researchers give medication (adenosine) that stimulates the heart and creates a situation similar to exercise. Stress Echocardiography with Dobutamine does not use radioactivity. It uses sound waves like standard echocardiography. During this echocardiogram patients receive doses of a medication called dobutamine that stimulates the heart to beat stronger and faster. The purpose of this study is to evaluate the accuracy of MCE compared to stress echocardiography at detecting coronary artery disease (CAD).
Details: Stress echocardiography has become a valuable technique for the non-invasive detection of coronary artery disease (CAD). Its accuracy has been shown to be superior to that of the exercise electrocardiogram and comparable to that of myocardial perfusion imaging. Myocardial contrast echocardiography (MCE) offers the potential to evaluate tissue perfusion at the level where oxygen transfer to the myocytes occurs. MCE can, therefore, provide information regarding the functional status of the myocardial microvasculature and presence of blood flow disparity. The purpose of this study is to evaluate the accuracy of MCE compared to stress echocardiography. We will correlate these results with findings from coronary angiography and compare the ability of those techniques to detect CAD.
Eligibility:
Study Type: Interventional, Treatment, Safety/Efficacy
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Patients with known or suspected coronary artery disease. Adults 18 years of age or older. No pre-menopausal patients who are lactating, pregnant or potentially pregnant as judged by history, physical examination, ultrasound or urine pregnancy test. No unstable angina patients. No recent myocardial infarction patients (less than 1 month). No frequent ectopy which precludes adequate image acquisition. No history of asthma or chronic obstructive pulmonary disease. No patients receiving aminophylline, theophylline or dipyridamole. No presence of second and third degree heart block without pacemaker. No significant hypertension (systolic blood pressure greater than 170 mm Hg) or hypotension (systolic blood pressure less than 100 mm Hg). No hypotension: basal sitting systolic arterial pressure less than 100 mm Hg confirmed 30 minutes later. No sinus tachycardia greater than or equal to 100 beats per min. No atrial fibrillation. No inadequate two-dimensional echocardiographic windows.
Total Enrollment: 150
Location and Contact Information:
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 990077; 99-H-0077
Study Start Date: March 26, 1999
Record last reviewed: February 9, 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001889
Other Coronary Disease Studies:
1. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2. Community Site Coronary Risk Control in Black Families
3. Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients with Coronary Artery Disease
4. Platelet Drug Trial in Coronary Disease Progression
5. Genetics of the Metabolic Syndrome in Japanese Americans
Related Studies:
Other Coronary Disease Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease
|
|
|
|
|
|
|
|
